Advertisement
DOCS vs NRDY
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DOCS is a Hold and NRDY is a StrongBuy.
DOCS in downward trend: price may decline as a result of having broken its higher Bollinger Band on October 20, 2026
DOCS broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 34 similar instances where the stock broke above the upper band. In 28 of the 34 cases the stock fell afterwards. This puts the odds of success at 82%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for DOCS moved out of overbought territory on October 29, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In 21 of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at 81%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 16 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Moving Average Convergence Divergence Histogram (MACD) for DOCS turned negative on October 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 32 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 74%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DOCS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on September 29, 2026. You may want to consider a long position or call options on DOCS as a result. In 58 of 75 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 77%.
The 50-day moving average for DOCS moved above the 200-day moving average on October 14, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +3.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where DOCS advanced for three days, in 210 of 281 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
The Aroon Indicator entered an Uptrend today. In 123 of 178 cases where DOCS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 69%.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. DOCS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 51 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 82 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 83 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.374) is normal, around the industry mean (4.705). P/E Ratio (36.400) is within average values for comparable stocks, (13.222). Projected Growth (PEG Ratio) (0.590) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (7.776) is also within normal values, averaging (6.065).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DOCS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.
Momentum Indicator for NRDY turns positive, indicating new upward trend
NRDY saw its Momentum Indicator move above the 0 level on October 30, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 79 similar instances where the indicator turned positive. In 66 of the 79 cases, the stock moved higher in the following days. The odds of a move higher are at 84%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where NRDY's RSI Indicator exited the oversold zone, 26 of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 45 of 60 cases where NRDY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.
The Moving Average Convergence Divergence (MACD) for NRDY just turned positive on October 20, 2026. Looking at past instances where NRDY's MACD turned positive, the stock continued to rise in 35 of 44 cases over the following month. The odds of a continued upward trend are 80%.
Following a +9.01% 3-day Advance, the price is estimated to grow further. Considering data from situations where NRDY advanced for three days, in 186 of 233 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
NRDY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NRDY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
The Aroon Indicator for NRDY entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 42 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.095) is normal, around the industry mean (-1.586). P/E Ratio (-1.677) is within average values for comparable stocks, (15.399). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.073) among similar stocks. P/S Ratio (0.399) is also within normal values, averaging (70.854).
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 88 (best 1 - 100 worst), indicating slightly worse than average price growth. NRDY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NRDY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
NRDY | ||
|---|---|---|
OUTLOOK RATING 1..100 | 22 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 42 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 99 | |
PRICE GROWTH RATING 1..100 | 88 | |
P/E GROWTH RATING 1..100 | 9 | |
SEASONALITY SCORE 1..100 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| DOCS | NRDY | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 81% | 3 days ago 76% |
| Stochastic ODDS (%) | 3 days ago 75% | 3 days ago 75% |
| Momentum ODDS (%) | 4 days ago 77% | 3 days ago 84% |
| MACD ODDS (%) | 3 days ago 74% | 3 days ago 80% |
| TrendWeek ODDS (%) | 3 days ago 77% | 3 days ago 80% |
| TrendMonth ODDS (%) | 3 days ago 78% | 3 days ago 88% |
| Advances ODDS (%) | 5 days ago 75% | 3 days ago 80% |
| Declines ODDS (%) | 3 days ago 79% | 6 days ago 89% |
| BollingerBands ODDS (%) | 3 days ago 82% | 3 days ago 82% |
| Aroon ODDS (%) | 3 days ago 69% | 3 days ago 83% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
DOCS’s FA Score shows that 0 FA rating(s) are green while NRDY’s FA Score has 1 green FA rating(s).
- DOCS’s FA Score: 0 green, 5 red.
- NRDY’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
DOCS’s TA Score shows that 4 TA indicator(s) are bullish while NRDY’s TA Score has 6 bullish TA indicator(s).
- DOCS’s TA Score: 4 bullish, 5 bearish.
- NRDY’s TA Score: 6 bullish, 2 bearish.
Price Growth
DOCS (@Services to the Health Industry) experienced а -1.89% price change this week, while NRDY (@Packaged Software) price change was +2.44% for the same time period.
The average weekly price growth across all stocks in the @Services to the Health Industry industry was +1.94%. For the same industry, the average monthly price growth was +1.00%, and the average quarterly price growth was +16.39%.
The average weekly price growth across all stocks in the @Packaged Software industry was -2.75%. For the same industry, the average monthly price growth was -3.40%, and the average quarterly price growth was -2.26%.
Reported Earning Dates
DOCS is expected to report earnings on Nov 05, 2026.
NRDY is expected to report earnings on Nov 09, 2026.
Industries' Descriptions
@Services to the Health Industry (+1.94% weekly)This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.
@Packaged Software (-2.75% weekly)Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.
Advertisement
DOCS and
Correlation & Price change
A.I.dvisor indicates that over the last year, DOCS has been loosely correlated with COIN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if DOCS jumps, then COIN could also see price increases.
| Ticker / NAME | Correlation To DOCS | 1D Price Change % | ||
|---|---|---|---|---|
| DOCS | 100% | -2.59% | ||
| COIN - DOCS | 57% Loosely correlated | -10.62% | ||
| PUBM - DOCS | 54% Loosely correlated | -6.58% | ||
| CLSK - DOCS | 53% Loosely correlated | -6.46% | ||
| COMP - DOCS | 53% Loosely correlated | -4.15% | ||
| RIOT - DOCS | 49% Loosely correlated | -6.77% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BBBL | 44.85 | -0.11 | -0.24% |
| BondBloxx BBB Rated 10+ Year Corporate Bond ETF (BBBL) | |||
| KMLM | 30.69 | -0.10 | -0.32% |
| KraneShares Mount Lucas Managed Futures Index Strategy ETF (KMLM) | |||
| FFIU | 20.90 | -0.10 | -0.48% |
| UVA Unconstrained Medium-Term Fixed Income ETF (FFIU) | |||
| GSIE | 46.15 | -0.38 | -0.82% |
| Goldman Sachs ActiveBeta International Equity ETF (GSIE) | |||
| JPXN | 100.31 | -1.54 | -1.51% |
| iShares JPX-Nikkei 400 ETF (JPXN) | |||